Agios Pharmaceuticals
AGIO
#5095
Rank
S$2.47 B
Marketcap
S$41.49
Share price
0.40%
Change (1 day)
-7.97%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: S$2.47 Billion

As of August 2026 Agios Pharmaceuticals has a market cap of S$2.47 Billion. This makes Agios Pharmaceuticals the world's 5095th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.47 B18.06%
2025S$2.09 B-18.98%
2024S$2.58 B57.5%
2023S$1.64 B-20.52%
2022S$2.06 B-14.29%
2021S$2.41 B-39.21%
2020S$3.97 B-9.84%
2019S$4.40 B20.07%
2018S$3.66 B-1.63%
2017S$3.72 B46.91%
2016S$2.53 B-26.7%
2015S$3.46 B-36.97%
2014S$5.49 B480.1%
2013S$0.94 B

End of Day market cap according to different sources

On Aug 9th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

S$2.46 Billion
by Nasdaq info icon info icon
S$2.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$197.81 B 7,886.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.386 T 55,882.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$133.42 B 5,287.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
S$1.99 B-19.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$16.72 B 575.19%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$16.57 B 569.23%๐Ÿ‡บ๐Ÿ‡ธ USA